Autopsy report · NCT01067859
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 8 months before it stopped.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Bayer
- Sponsor type
- Industry
- Conditions
- Acute Heart Failure
- Interventions
- Cinaciguat (BAY58-2667); Cinaciguat (BAY58-2667); Placebo
- Participants
- 5
- Sites
- 30
- Countries
- Argentina, Austria, Belgium, France, Germany, Ireland, Mexico, Philippines, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.